Diagnostic value of Xpert^® Bladder Cancer Monitor in the follow-up of patients affected by non-muscle invasive bladder cancer: an update

Abstract

Our data confirm a significantly higher sensitivity of Xpert^® Bladder Cancer Monitor than for cytology in a larger patient cohort. The test performed very well in terms of specificity but could not reach the high value of cytology. Along with voided urinary cytology the test could allow to reduce cystoscopies in follow-up patients, reducing discomfort to the patients and costs.